Comparison of CBD stenting and standard endoscopic treatment in large and multiple CBD stones

Not Applicable

Recruiting

• Conditions: CBD stones.; Calculus of bile duct without cholangitis or cholecystitis, Calculus of bile duct with cholecystitis, Calculus of bile duct with cholangitis; K80.5, K80

• Registration Number: IRCT2017020831252N4
• Lead Sponsor: Qom University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 64

Inclusion Criteria

CBD stone with a diameter greater than 15mm; More than 3 stones in CBD
Exclusion criteria: History of recent surgery on bile ducts; History of gasterectomy; History of duodenal stricture; Patients who don not fill the informed concept form

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Common bile duct clearing. Timepoint: 2 months after CBD stenting. Method of measurement: By ERCP.

Secondary Outcome Measures

Name	Time	Method
Chollangitis. Timepoint: After ERCP. Method of measurement: According to Charcot's triad including abdominal pain, serum bilirubin measurement and core body temperature measurement.;Pancreatitis. Timepoint: After ERCP. Method of measurement: Serum Amylase level measurement.;Bile ducts perforation. Timepoint: During ERCP. Method of measurement: By ERCP.;Reduction in stones size. Timepoint: 2 months after CBD stenting. Method of measurement: By ERCP.;Reduction in stone number. Timepoint: 2 months after CBD stenting. Method of measurement: By ERCP.;Isolated pain. Timepoint: After ERCP. Method of measurement: Patient's statements.